DOCMZ Stock Overview

Operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. More details

DOCMZ fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	1/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Rewards

Trading at 84.5% below our estimate of its fair value

Revenue is forecast to grow 15.49% per year

Trading at good value compared to peers and industry

Risk Analysis

Highly volatile share price over the past 3 months compared to the UK market

Currently unprofitable and not forecast to become profitable over the next 3 years

DocMorris AG Competitors

Kitwave Group

AIM:KITW

UK£226.1m

Naked Wines

AIM:WINE

UK£58.2m

Cake Box Holdings

AIM:CBOX

UK£78.1m

Virgin Wines UK

AIM:VINO

UK£23.5m

Price History & Performance

Summary of share price highs, lows and changes for DocMorris
Historical stock prices
Current Share Price	CHF 20.32
52 Week High	CHF 88.25
52 Week Low	CHF 14.93
Beta	1.88
1 Month Change	15.65%
3 Month Change	-4.33%
1 Year Change	-75.35%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-86.44%

Recent updates

Shareholder Returns

	DOCMZ	GB Consumer Retailing	GB Market
7D	2.9%	8.3%	4.0%
1Y	-75.4%	23.4%	2.1%

Return vs Industry: DOCMZ underperformed the UK Consumer Retailing industry which returned 22.4% over the past year.

Return vs Market: DOCMZ underperformed the UK Market which returned 2.3% over the past year.

Price Volatility

Is DOCMZ's price volatile compared to industry and market?
DOCMZ volatility
DOCMZ Average Weekly Movement	10.6%
Consumer Retailing Industry Average Movement	4.8%
Market Average Movement	5.6%
10% most volatile stocks in GB Market	10.6%
10% least volatile stocks in GB Market	3.2%

Stable Share Price: DOCMZ's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: DOCMZ's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

Founded	Employees	CEO	Website
1993	1,454	Walter Hess	corporate.docmorris.com/en

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services.

DocMorris AG Fundamentals Summary

How do DocMorris's earnings and revenue compare to its market cap?
DOCMZ fundamental statistics
Market cap	CHF 241.06m
Earnings (TTM)	-CHF 97.25m
Revenue (TTM)	CHF 1.02b

0.2x

P/S Ratio

-2.5x

P/E Ratio

Is DOCMZ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DOCMZ income statement (TTM)
Revenue	CHF 1.02b
Cost of Revenue	CHF 800.50m
Gross Profit	CHF 216.54m
Other Expenses	CHF 313.80m
Earnings	-CHF 97.25m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 19, 2025

Earnings per share (EPS)	-8.23
Gross Margin	21.29%
Net Profit Margin	-9.56%
Debt/Equity Ratio	84.0%

How did DOCMZ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/19 07:10
End of Day Share Price	2025/04/17 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DocMorris AG is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Bosse	Baader Helvea Equity Research
Gerhard Orgonas	Berenberg
Ashley Wallace	BofA Global Research